Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
126.08 USD | -0.32% |
|
+2.92% | +7.50% |
03:21pm | Oberon Announces Partnership with TD SYNNEX | CI |
06-11 | TD Synnex to Benefit From IT Spending, Exposure to Cloud Capex, Morgan Stanley Says | MT |
Fiscal Period: November | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.03 | 2.23 | 2.98 | 2.75 | 2.65 | |||||
Return on Total Capital | 8.6 | 4.91 | 6.81 | 6.42 | 6.28 | |||||
Return On Equity % | 13.02 | 6.45 | 8.18 | 7.74 | 8.5 | |||||
Return on Common Equity | 12.88 | 6.39 | 8.12 | 7.68 | 8.42 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 11.89 | 5.98 | 6.41 | 6.9 | 6.81 | |||||
SG&A Margin | 7.78 | 3.65 | 4.21 | 4.64 | 4.65 | |||||
EBITDA Margin % | 5.49 | 2.81 | 2.94 | 2.98 | 2.86 | |||||
EBITA Margin % | 4.87 | 2.66 | 2.68 | 2.77 | 2.67 | |||||
EBIT Margin % | 4.11 | 2.33 | 2.2 | 2.26 | 2.16 | |||||
Income From Continuing Operations Margin % | 2.14 | 1.25 | 1.04 | 1.09 | 1.18 | |||||
Net Income Margin % | 2.14 | 1.25 | 1.04 | 1.09 | 1.18 | |||||
Net Avail. For Common Margin % | 2.12 | 1.24 | 1.04 | 1.08 | 1.17 | |||||
Normalized Net Income Margin | 2.23 | 1.14 | 1.14 | 1.1 | 1 | |||||
Levered Free Cash Flow Margin | 6.94 | -1.05 | 0.19 | 2.63 | 1.71 | |||||
Unlevered Free Cash Flow Margin | 7.22 | -0.75 | 0.38 | 2.89 | 1.99 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.96 | 1.54 | 2.17 | 1.95 | 1.96 | |||||
Fixed Assets Turnover | 28.1 | 54.56 | 70.93 | 66.61 | 63.89 | |||||
Receivables Turnover (Average Receivables) | 6.33 | 5.7 | 7.03 | 5.84 | 5.66 | |||||
Inventory Turnover (Average Inventory) | 8.31 | 6.37 | 7.43 | 6.61 | 7.06 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.56 | 1.25 | 1.25 | 1.2 | 1.24 | |||||
Quick Ratio | 1.02 | 0.73 | 0.66 | 0.73 | 0.72 | |||||
Operating Cash Flow to Current Liabilities | 0.33 | 0.06 | -0 | 0.08 | 0.07 | |||||
Days Sales Outstanding (Average Receivables) | 57.83 | 64.09 | 51.9 | 62.53 | 64.62 | |||||
Days Outstanding Inventory (Average Inventory) | 44.04 | 57.26 | 49.14 | 55.22 | 51.85 | |||||
Average Days Payable Outstanding | 58.89 | 85.53 | 78.15 | 96.57 | 93.56 | |||||
Cash Conversion Cycle (Average Days) | 42.97 | 35.82 | 22.89 | 21.18 | 22.91 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 80.49 | 58.97 | 56.4 | 55.61 | 54.78 | |||||
Total Debt / Total Capital | 44.6 | 37.09 | 36.06 | 35.74 | 35.39 | |||||
LT Debt/Equity | 69.95 | 54.8 | 51.95 | 42.43 | 51.36 | |||||
Long-Term Debt / Total Capital | 38.75 | 34.47 | 33.21 | 27.27 | 33.18 | |||||
Total Liabilities / Total Assets | 67.79 | 71.42 | 73.01 | 72.18 | 73.46 | |||||
EBIT / Interest Expense | 9.14 | 4.8 | 6.97 | 5.48 | 4.83 | |||||
EBITDA / Interest Expense | 14.95 | 6.14 | 9.97 | 7.81 | 6.91 | |||||
(EBITDA - Capex) / Interest Expense | 13.16 | 5.78 | 9.38 | 7.18 | 6.24 | |||||
Total Debt / EBITDA | 2.11 | 4.96 | 2.31 | 2.46 | 2.43 | |||||
Net Debt / EBITDA | 1.16 | 3.9 | 2.04 | 1.9 | 1.85 | |||||
Total Debt / (EBITDA - Capex) | 2.39 | 5.26 | 2.46 | 2.67 | 2.69 | |||||
Net Debt / (EBITDA - Capex) | 1.32 | 4.14 | 2.17 | 2.07 | 2.04 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 3.87 | 58.25 | 97.2 | -7.68 | 1.56 | |||||
Gross Profit, 1 Yr. Growth % | 1.25 | 58.27 | 108.9 | -0.61 | 0.24 | |||||
EBITDA, 1 Yr. Growth % | 7.18 | 41.51 | 101.28 | -6.28 | -2.6 | |||||
EBITA, 1 Yr. Growth % | 8.91 | 39.67 | 93.08 | -4.53 | -2.21 | |||||
EBIT, 1 Yr. Growth % | 13.59 | 30.91 | 80.45 | -5.11 | -2.6 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 5.68 | 18.09 | 64.86 | -3.75 | 9.92 | |||||
Net Income, 1 Yr. Growth % | 5.68 | -25.34 | 64.86 | -3.75 | 9.92 | |||||
Normalized Net Income, 1 Yr. Growth % | 20.6 | 21.42 | 74.82 | -10.93 | -6.27 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 4.86 | -2.78 | 8.61 | -1.1 | 18.72 | |||||
Accounts Receivable, 1 Yr. Growth % | -1.42 | 197.67 | 13.37 | 9.31 | 0.43 | |||||
Inventory, 1 Yr. Growth % | 5.39 | 147.49 | 36.49 | -21.18 | 15.96 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 108.15 | 307.75 | -11.1 | 8.92 | 3.1 | |||||
Total Assets, 1 Yr. Growth % | 15.14 | 105.41 | 7.47 | -1.08 | 2.93 | |||||
Tangible Book Value, 1 Yr. Growth % | 194.19 | -124.79 | -78.23 | -117.24 | 557.36 | |||||
Common Equity, 1 Yr. Growth % | 14.53 | 82.21 | 1.51 | 1.96 | -1.81 | |||||
Cash From Operations, 1 Yr. Growth % | 233.57 | -55.85 | -106.13 | -2.94K | -13.48 | |||||
Capital Expenditures, 1 Yr. Growth % | 44.06 | -72.27 | 113.24 | 28.16 | 16.74 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 450.59 | -127.62 | -140.65 | 1.2K | -33.51 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 339.47 | -118.9 | -208.35 | 594.75 | -30.06 | |||||
Dividend Per Share, 1 Yr. Growth % | -73.33 | 125 | 38.89 | 16 | 13.1 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 11.73 | 28.76 | 76.66 | 34.93 | -3.17 | |||||
Gross Profit, 2 Yr. CAGR % | 23.4 | 27.78 | 82.96 | 44.98 | 1.03 | |||||
EBITDA, 2 Yr. CAGR % | 32.14 | 22.96 | 75.68 | 39.15 | -1.85 | |||||
EBITA, 2 Yr. CAGR % | 33.37 | 22.06 | 71.26 | 37.66 | -0.46 | |||||
EBIT, 2 Yr. CAGR % | 35.65 | 18.87 | 60.93 | 32.92 | -0.3 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 32.81 | 4.44 | 39.53 | 25.97 | 2.86 | |||||
Net Income, 2 Yr. CAGR % | 32.81 | -11.17 | 10.94 | 25.97 | 2.86 | |||||
Normalized Net Income, 2 Yr. CAGR % | 38.87 | 14.14 | 59.95 | 32.17 | -5.49 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 19.34 | -5.75 | 2.76 | 3.64 | 8.36 | |||||
Accounts Receivable, 2 Yr. CAGR % | 3.11 | 45.47 | 83.7 | 11.32 | 4.77 | |||||
Inventory, 2 Yr. CAGR % | 5.93 | 61.49 | 83.79 | 3.72 | -4.4 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 44.09 | 27.78 | 90.39 | -1.6 | 5.97 | |||||
Total Assets, 2 Yr. CAGR % | 8.02 | 53.79 | 48.58 | 3.11 | 0.9 | |||||
Tangible Book Value, 2 Yr. CAGR % | 174.13 | 57.67 | -76.77 | -80.63 | 6.47 | |||||
Common Equity, 2 Yr. CAGR % | 12.39 | 44.46 | 36 | 1.74 | 0.06 | |||||
Cash From Operations, 2 Yr. CAGR % | 326.79 | 21.35 | -83.56 | 31.83 | 395.47 | |||||
Capital Expenditures, 2 Yr. CAGR % | 25.69 | -36.8 | -23.11 | 65.31 | 22.31 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 180.39 | 32.71 | -68.73 | 153.58 | 272.3 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 221.32 | 28.3 | -56.09 | 165.69 | 154.66 | |||||
Dividend Per Share, 2 Yr. CAGR % | -46.55 | -22.54 | 76.78 | 26.93 | 14.54 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 13.74 | 16.94 | 48.42 | 42.29 | 22.74 | |||||
Gross Profit, 3 Yr. CAGR % | 23.72 | -0.65 | 51.15 | 49.28 | 28.2 | |||||
EBITDA, 3 Yr. CAGR % | 26.63 | 4.56 | 46.18 | 42.48 | 23.55 | |||||
EBITA, 3 Yr. CAGR % | 26.97 | 7.59 | 43.53 | 40.95 | 22.83 | |||||
EBIT, 3 Yr. CAGR % | 25.93 | 10.12 | 38.06 | 34.94 | 19.84 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 20.79 | 9.61 | 21.61 | 23.29 | 20.37 | |||||
Net Income, 3 Yr. CAGR % | 20.79 | 9.61 | 9.16 | 5.81 | 20.37 | |||||
Normalized Net Income, 3 Yr. CAGR % | 23.89 | 8.22 | 36.71 | 31.59 | 17.44 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 10.93 | -4.55 | -1.18 | 1.46 | 8.44 | |||||
Accounts Receivable, 3 Yr. CAGR % | 10.79 | 31.67 | 33.87 | 54.51 | 7.56 | |||||
Inventory, 3 Yr. CAGR % | 7.47 | 40.55 | 52.68 | 38.6 | 7.65 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 50.7 | 17.66 | 13.23 | 58.05 | -0.06 | |||||
Total Assets, 3 Yr. CAGR % | 20.5 | 33.83 | 36.47 | 29.74 | 3.05 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.73 | 85.18 | -18.51 | -78.97 | -37.28 | |||||
Common Equity, 3 Yr. CAGR % | 23.85 | 32.03 | 28.43 | 23.55 | 0.54 | |||||
Cash From Operations, 3 Yr. CAGR % | 118.12 | 100.34 | -55.15 | -8.45 | 14.57 | |||||
Capital Expenditures, 3 Yr. CAGR % | 26.61 | -24.05 | -5.21 | -8.83 | 47.21 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 180.55 | 15.04 | -14.69 | 8.25 | 61.89 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 218.65 | 10.98 | 18.7 | 10.23 | 70.28 | |||||
Dividend Per Share, 3 Yr. CAGR % | -27.51 | -13.69 | -5.9 | 53.62 | 22.14 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 13.09 | 17.59 | 30.03 | 23.83 | 25.11 | |||||
Gross Profit, 5 Yr. CAGR % | 19.74 | 8.05 | 20.87 | 15.57 | 28.03 | |||||
EBITDA, 5 Yr. CAGR % | 23.68 | 11.65 | 22.39 | 17.22 | 23.31 | |||||
EBITA, 5 Yr. CAGR % | 23.41 | 13.54 | 23.26 | 18.74 | 22.52 | |||||
EBIT, 5 Yr. CAGR % | 22.68 | 13.52 | 21.97 | 18.73 | 19.45 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 20.46 | 10.95 | 16.75 | 15.88 | 13.73 | |||||
Net Income, 5 Yr. CAGR % | 20.47 | 10.95 | 16.75 | 15.88 | 6.6 | |||||
Normalized Net Income, 5 Yr. CAGR % | 21.17 | 9.87 | 19.63 | 17.23 | 16.11 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 14.29 | 1.18 | -1.97 | -1.35 | 2.53 | |||||
Accounts Receivable, 5 Yr. CAGR % | 17.08 | 36.45 | 27.05 | 23.12 | 21.37 | |||||
Inventory, 5 Yr. CAGR % | 15.1 | 30.7 | 33.2 | 24.46 | 26.61 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 36.69 | 24.37 | 19 | 9.54 | 10.26 | |||||
Total Assets, 5 Yr. CAGR % | 24.83 | 39.62 | 31.03 | 20.57 | 20.95 | |||||
Tangible Book Value, 5 Yr. CAGR % | -3.89 | -4.94 | -24.64 | -24.93 | -9.31 | |||||
Common Equity, 5 Yr. CAGR % | 19.25 | 31.96 | 28.58 | 18.96 | 16.23 | |||||
Cash From Operations, 5 Yr. CAGR % | 23.39 | 20.05 | -22.44 | 69.46 | 17.23 | |||||
Capital Expenditures, 5 Yr. CAGR % | 14.61 | -14.93 | 3.71 | 3.66 | 4.97 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 30.11 | 7.71 | 8.55 | 47.42 | 39.67 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 30.52 | -0.49 | 34.2 | 57.36 | 52.05 | |||||
Dividend Per Share, 5 Yr. CAGR % | -7.16 | 1.15 | 3.55 | 0.7 | 1.8 |
- Stock Market
- Equities
- SNX Stock
- Financials TD SYNNEX Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition